GLP-1 Agonists Show Superior Benefits Over Metformin in Prediabetes Management | Retatrutide News

GLP-1 receptor agonists outperform Metformin in reducing prediabetes risk and MACE. This highlights their potential to improve treatment strategies for ...
Clinical Trials · November 4, 2026